Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB. Borisov SE, et al. Eur Respir J. 2017 May 21;49(5):1700387. doi: 10.1183/13993003.00387-2017. Print 2017 May. Eur Respir J. 2017. PMID: 28529205 Free article.
Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.
Borisov SE, D'Ambrosio L, Centis R, Tiberi S, Dheda K, Alffenaar JW, Amale R, Belilowski E, Bruchfeld J, Canneto B, Denholm J, Duarte R, Esmail A, Filippov A, Davies Forsman L, Gaga M, Ganatra S, Igorevna GA, Lazaro Mastrapa B, Manfrin V, Manga S, Maryandyshev A, Massard G, González Montaner P, Mullerpattan J, Palmero DJ, Pontarelli A, Papavasileiou A, Pontali E, Romero Leyet R, Spanevello A, Udwadia ZF, Viggiani P, Visca D, Sotgiu G, Migliori GB. Borisov SE, et al. J Infect. 2019 Jan;78(1):35-39. doi: 10.1016/j.jinf.2018.08.003. Epub 2018 Aug 7. J Infect. 2019. PMID: 30096332
Nomenclature of drug-resistant tuberculosis.
Udwadia ZF, Amale RA, Ajbani KK, Rodrigues CS. Udwadia ZF, et al. Among authors: amale ra. Lancet Infect Dis. 2013 Nov;13(11):917. doi: 10.1016/S1473-3099(13)70291-3. Lancet Infect Dis. 2013. PMID: 24156895 No abstract available.
Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
Maryandyshev A, Pontali E, Tiberi S, Akkerman O, Ganatra S, Sadutshang TD, Alffenaar JW, Amale R, Mullerpattan J, Topgyal S, Udwadia ZF, Centis R, D'Ambrosio L, Sotgiu G, Migliori GB. Maryandyshev A, et al. Emerg Infect Dis. 2017 Oct;23(10):1718-21. doi: 10.3201/eid2310.170834. Epub 2017 Oct 17. Emerg Infect Dis. 2017. PMID: 28758888 Free PMC article.
Totally drug-resistant tuberculosis in India.
Udwadia ZF, Amale RA, Ajbani KK, Rodrigues C. Udwadia ZF, et al. Among authors: amale ra. Clin Infect Dis. 2012 Feb 15;54(4):579-81. doi: 10.1093/cid/cir889. Epub 2011 Dec 21. Clin Infect Dis. 2012. PMID: 22190562 No abstract available.
Importance of Therapeutic Drug Monitoring of Rifampicin.
Chawla PK, Udwadia ZF, Soman R, Mahashur AA, Amale RA, Dherai AJ, Lokhande RV, Naik PR, Ashavaid TF. Chawla PK, et al. Among authors: amale ra. J Assoc Physicians India. 2016 Aug;64(8):68-72. J Assoc Physicians India. 2016. PMID: 27762112 Review.